Soleimani, M., Thi, M., Janfaza, S., Ozcan, G., Mazurek, S., Ozgun, G., Maurice-Dror, C., Eigl, B., Chi, K., Kollmannsberger, C., Nappi, L. (2025). Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-025-99376-z